Svenja Haag1,2, Alexander Jobs3,4,5,6, Thomas Stiermaier1,2, Carlo-Federico Fichera1,2, Christina Paitazoglou1,2, Ingo Eitel1,2, Steffen Desch1,2,7,8, Holger Thiele7,8. 1. Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, Medical Clinic II, University Hospital Schleswig-Holstein, Lübeck, Germany. 2. German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany. 3. Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, Medical Clinic II, University Hospital Schleswig-Holstein, Lübeck, Germany. alexander.jobs@medizin.uni-leipzig.de. 4. German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany. alexander.jobs@medizin.uni-leipzig.de. 5. Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. alexander.jobs@medizin.uni-leipzig.de. 6. Leipzig Heart Institute, Leipzig, Germany. alexander.jobs@medizin.uni-leipzig.de. 7. Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. 8. Leipzig Heart Institute, Leipzig, Germany.
Abstract
BACKGROUND: Hospitalizations for acute decompensated heart failure (ADHF) are commonly associated with congestion-related signs and symptoms. Objective and quantitative markers of congestion have been identified, but there is limited knowledge regarding the correlation between these markers. METHODS: Patients hospitalized for ADHF irrespective of left ventricular ejection fraction were included in a prospective registry. Assessment of congestion markers (e.g., NT-proBNP, maximum inferior vena cava diameter, dyspnea using visual analogue scale, and a clinical congestion score) was performed systematically on admission and at discharge. Telephone interviews were performed to assess clinical events, i.e., all-cause death or readmission for cardiovascular cause, after discharge. Missing values were handled by multiple imputation. RESULTS: In total, 130 patients were prospectively enrolled. Median length of hospitalization was 9 days (interquartile range 6 to 16). All congestion markers declined from admission to discharge (p < 0.001). No correlation between the congestion markers could be identified, neither on admission nor at discharge. The composite endpoint of all-cause death or readmission for cardiovascular cause occurred in 46.2% of patients. Only NT-proBNP at discharge was predictive for this outcome (hazard ratio 1.48, 95% confidence interval 1.15 to 1.90, p = 0.002). CONCLUSION: No correlation between quantitative congestion markers was observed. Only NT-proBNP at discharge was significantly associated with the composite endpoint of all-cause death or readmission for cardiovascular cause. Findings indicate that the studied congestion markers reflect different aspects of congestion.
BACKGROUND: Hospitalizations for acute decompensated heart failure (ADHF) are commonly associated with congestion-related signs and symptoms. Objective and quantitative markers of congestion have been identified, but there is limited knowledge regarding the correlation between these markers. METHODS: Patients hospitalized for ADHF irrespective of left ventricular ejection fraction were included in a prospective registry. Assessment of congestion markers (e.g., NT-proBNP, maximum inferior vena cava diameter, dyspnea using visual analogue scale, and a clinical congestion score) was performed systematically on admission and at discharge. Telephone interviews were performed to assess clinical events, i.e., all-cause death or readmission for cardiovascular cause, after discharge. Missing values were handled by multiple imputation. RESULTS: In total, 130 patients were prospectively enrolled. Median length of hospitalization was 9 days (interquartile range 6 to 16). All congestion markers declined from admission to discharge (p < 0.001). No correlation between the congestion markers could be identified, neither on admission nor at discharge. The composite endpoint of all-cause death or readmission for cardiovascular cause occurred in 46.2% of patients. Only NT-proBNP at discharge was predictive for this outcome (hazard ratio 1.48, 95% confidence interval 1.15 to 1.90, p = 0.002). CONCLUSION: No correlation between quantitative congestion markers was observed. Only NT-proBNP at discharge was significantly associated with the composite endpoint of all-cause death or readmission for cardiovascular cause. Findings indicate that the studied congestion markers reflect different aspects of congestion.
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Khibar Salah; Wouter E Kok; Luc W Eurlings; Paulo Bettencourt; Joana M Pimenta; Marco Metra; Antoni Bayes-Genis; Valerio Verdiani; Luca Bettari; Valentina Lazzarini; Peter Damman; Jan G Tijssen; Yigal M Pinto Journal: Heart Date: 2013-10-31 Impact factor: 5.994
Authors: Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller Journal: JAMA Date: 2005-10-05 Impact factor: 56.272
Authors: Nicolas Girerd; Marie-France Seronde; Stefano Coiro; Tahar Chouihed; Pascal Bilbault; François Braun; David Kenizou; Bruno Maillier; Pierre Nazeyrollas; Gérard Roul; Ludivine Fillieux; William T Abraham; James Januzzi; Laurent Sebbag; Faiez Zannad; Alexandre Mebazaa; Patrick Rossignol Journal: JACC Heart Fail Date: 2017-12-06 Impact factor: 12.035
Authors: Theresa A McDonagh; Marco Metra; Marianna Adamo; Roy S Gardner; Andreas Baumbach; Michael Böhm; Haran Burri; Javed Butler; Jelena Čelutkienė; Ovidiu Chioncel; John G F Cleland; Andrew J S Coats; Maria G Crespo-Leiro; Dimitrios Farmakis; Martine Gilard; Stephane Heymans; Arno W Hoes; Tiny Jaarsma; Ewa A Jankowska; Mitja Lainscak; Carolyn S P Lam; Alexander R Lyon; John J V McMurray; Alexandre Mebazaa; Richard Mindham; Claudio Muneretto; Massimo Francesco Piepoli; Susanna Price; Giuseppe M C Rosano; Frank Ruschitzka; Anne Kathrine Skibelund Journal: Eur Heart J Date: 2021-09-21 Impact factor: 29.983
Authors: Wilfried Mullens; Kevin Damman; Veli-Pekka Harjola; Alexandre Mebazaa; Hans-Peter Brunner-La Rocca; Pieter Martens; Jeffrey M Testani; W H Wilson Tang; Francesco Orso; Patrick Rossignol; Marco Metra; Gerasimos Filippatos; Petar M Seferovic; Frank Ruschitzka; Andrew J Coats Journal: Eur J Heart Fail Date: 2019-01-01 Impact factor: 15.534
Authors: Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter Journal: Eur J Heart Fail Date: 2010-08-22 Impact factor: 15.534
Authors: Sascha N Goonewardena; Anthony Gemignani; Adam Ronan; Samip Vasaiwala; John Blair; J Matthew Brennan; Dipak P Shah; Kirk T Spencer Journal: JACC Cardiovasc Imaging Date: 2008-09
Authors: Scott D Solomon; Joanna Dobson; Stuart Pocock; Hicham Skali; John J V McMurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; James B Young; Eric L Michelson; Marc A Pfeffer Journal: Circulation Date: 2007-08-27 Impact factor: 29.690
Authors: Sara Pérez-Herrero; Noel Lorenzo-Villalba; Elena Urbano; Beatriz Sánchez-Sauce; Fernando Aguilar-Rodríguez; Máximo Bernabeu-Wittel; Rocio Garcia-Alonso; Llanos Soler-Rangel; Francisco Trapiello-Valbuena; Alejandra Garcia-García; Jose Manuel Casas-Rojo; Luis Beltrán-Romero; Lucia De Jorge-Huerta; Juan Igor Molina-Puente; Emmanuel Andrès; Rosario Iguarán-Bermúdez; Manuel Méndez-Bailón Journal: J Clin Med Date: 2022-08-05 Impact factor: 4.964